HCR Wealth Advisors
Source: SEC Form 13F · as of Mar 2026HCR Wealth Advisors holds 12 biotech & pharma companies tracked by BioSniper, totaling $13.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$13.3M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 14,175 | $3.1M |
| JNJJOHNSON & JOHNSON | 11,899 | $2.9M |
| AMGNAMGEN INC | 4,813 | $1.7M |
| ZTSZoetis Inc. | 11,752 | $1.4M |
| LLYELI LILLY & Co | 1,351 | $1.2M |
| PMPhilip Morris International Inc | 6,345 | $1.0M |
| MRKMerck & Co., Inc. | 4,609 | $554K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,937 | $524K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 924 | $306K |
| NVONovo Nordisk A/S | 7,585 | $279K |
| IDXXIDEXX LABORATORIES INC /DE | 366 | $206K |
| NTHINEONC TECHNOLOGIES HOLDINGS, INC. | 15,000 | $105K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.